Loading...
Loading...
India's losartan imports from IRELAND total $815 across 2 shipments from 2 foreign suppliers. NEWLIFE BIOPHARMA LIMTED leads with $569 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include TORRENT PHARMACEUTICALS LTD. This corridor reflects India's pharmaceutical import demand for losartan โ a concentrated sourcing relationship with select suppliers from IRELAND.

NEWLIFE BIOPHARMA LIMTED is the leading Losartan supplier from IRELAND to India, with import value of $569 across 1 shipments. The top 5 suppliers โ NEWLIFE BIOPHARMA LIMTED, NEWLIFE BIOPHARMA LIMITED. โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEWLIFE BIOPHARMA LIMTED | $569 | 1 | 69.8% |
| 2 |
| NEWLIFE BIOPHARMA LIMITED. |
| $246 |
| 1 |
| 30.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD | $569 | 1 | 69.8% |
| 2 | UNISON PHARMACEUTICALS PRIVATE LIMITED | $246 | 1 | 30.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Losartan suppliers from IRELAND to India include NEWLIFE BIOPHARMA LIMTED, NEWLIFE BIOPHARMA LIMITED.. The leading supplier is NEWLIFE BIOPHARMA LIMTED with import value of $569 USD across 1 shipments. India imported Losartan worth $815 USD from IRELAND in total across 2 shipments.
India imported Losartan worth $815 USD from IRELAND across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Losartan sourced from IRELAND include TORRENT PHARMACEUTICALS LTD, UNISON PHARMACEUTICALS PRIVATE LIMITED. The largest buyer is TORRENT PHARMACEUTICALS LTD with $569 in imports across 1 shipments.
The total value of Losartan imports from IRELAND to India is $815 USD, across 2 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists